Top Markets
Coin of the day
OS Therapies Incorporated OS Therapies Incorporated

OS Therapies Incorporated

OSTX
株式のランク #23564
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses... OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
株価
$1.58
最終同期: 2026-08-21
時価総額
$71.95M
変化(1日)
0.64%
変化(1年)
-36.29%
US
取引 OS Therapies Incorporated (OSTX)

カテゴリー

OS Therapies Incorporated(OSTX)のEPS
2026 時点のEPS TTM: 0
OS Therapies Incorporatedの最新の財務報告と株価によると、同社の現在のEPS(TTM)は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
OS Therapies IncorporatedのEPS履歴(2026から2026まで)
各年末時点のEPS
EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH